Skip to main content

Windtree Therapeutics Inc

WINT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000946486

No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Windtree Therapeutics Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of WINT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders2127+6
Shares1.11M1.72M+612.5K (+55.2%)
Value$2.72M$3.94M+$1.23M (+45.2%)

New holders (12)

Institutions that held Windtree Therapeutics Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to WINT in Q2 2021
InstitutionSharesValue% of portfolio
Skandinaviska Enskilda Banken AB (publ)95,500$219.0K0.00%
Geode Capital Management, LLC69,082$158.0K0.00%
Goldman Sachs Group Inc66,952$153.0K0.00%
Frontier Wealth Management LLC60,000$137.0K0.01%
BlackRock Inc.57,556$132.0K0.00%
Jane Street Group, LLC32,017$73.0K0.00%
Tower Research Capital LLC (TRC)26,991$62.0K0.00%
State Street Corp19,300$44.0K0.00%
Moloney Securities Asset Management, LLC10,890$25.0K0.00%
Two Sigma Securities, LLC10,139$23.0K0.01%
Advisory Services Network, LLC2,000$5.00K0.00%
Tradewinds Capital Management, LLC400$1.00K0.00%

Sold out (6)

Institutions that held Windtree Therapeutics Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of WINT in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Affinity Asset Advisors, LLC42,847$105.0K
HRT Financial LP23,365$57.0K
Sowell Financial Services LLC4,137$9.00K
Bank of America Corp22$0
Morgan Stanley1$0
MCF Advisors LLC20$0